JUVA LIFE INC. | Sales 2021 | 3.87 5.29 | Sales 2022 | 5.76 7.88 | Capitalization | 10.4M 14.21M |
|---|---|---|---|---|---|
| Net income 2021 | -11M -15.04M | Net income 2022 | -10M -13.67M | EV / Sales 2021 | 8,085,207 x |
| Net Debt 2021 | 1.62M 2.22M | Net Debt 2022 | 7.38M 10.09M | EV / Sales 2022 | 3,084,662 x |
| P/E ratio 2021 |
-2.51
x | P/E ratio 2022 |
-0.99
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 52.48% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Douglas Chloupek
CEO | Chief Executive Officer | - | - |
Mathew Lee
DFI | Director of Finance/CFO | 40 | 19-04-02 |
Dan Hughes
COO | Chief Operating Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kari A. Gothie
ADM | Chief Administrative Officer | - | 19-05-29 |
Mathew Lee
DFI | Director of Finance/CFO | 40 | 19-04-02 |
Douglas Chloupek
CEO | Chief Executive Officer | - | - |
Juva Life Inc. is a Canada-based life science company with both pharmaceutical research and development and consumer-facing operations in cannabis production and distribution. The principal business of the Company is to acquire, own, and operate various cannabis businesses in the state of California. Its segments include the resale of merchandise and cannabis derived products, and cultivation and sale of trim and flowers. The Company is vertically integrated and consists of five divisions: Juva Cultivation, Juva Research, Juva Manufacturing, Juva Distribution, and Juva Retail. Juva Cultivation focuses on cultivating and distributing cannabis to medical and recreational cannabis users. Juva Retail is a network of retail cannabis facilities that serves the San Francisco Bay Area and other areas. It leverages revenue derived from its retail operations to advance JUVA-019, JUVA-041, and other potentially valuable non-cannabinoid bio actives for consumer and pharma product applications.
Sector
Pharmaceuticals
Calendar
2024-05-23
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +23.05% | 3.66B | |
| +109.78% | 2B | |
| +87.30% | 61.69M |
